Clinical Trial Update: Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 study called Symbiotic-Lung-10 evaluating PF-08634404 alone or with a partner in early-stage or locally advanced non-small cell lung cancer; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: NOT_YET_RECRUITING